Drugs in Development for Hepatitis B

With high morbidity and mortality worldwide, there is great interest in effective therapies for chronic hepatitis B (CHB) virus. There are currently several dozen investigational agents being developed for treatment of CHB. They can be broadly divided into two categories: (1) direct-acting antiviral...

Descripción completa

Detalles Bibliográficos
Autores principales: Dawood, Altaf, Abdul Basit, Syed, Jayaraj, Mahendran, Gish, Robert G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Leading Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5529495/
https://www.ncbi.nlm.nih.gov/pubmed/28660478
http://dx.doi.org/10.1007/s40265-017-0769-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5529495/
https://www.ncbi.nlm.nih.gov/pubmed/28660478
http://dx.doi.org/10.1007/s40265-017-0769-2

Ejemplares similares